| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6094304 | Gastroenterology | 2014 | 14 Pages |
Abstract
Administration of GLP-2 to men causes the release of chylomicrons that comprise previously synthesized and stored apoB-48 and lipids. This transiently increases TRL apoB-48 levels compared with placebo. Clinical trials number at www.clinicaltrials.gov: NCT 01958775.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Satya Dash, Changting Xiao, Cecilia Morgantini, Philip W. Connelly, Bruce W. Patterson, Gary F. Lewis,